Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Open BEU2019 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from the Benelux countries Belgium, Luxembourg and The Netherlands or involving organisations from these countries.

Total search results: 1617 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Ra Pharmaceuticals–UCB: investment, 201910– acquisition $2.5b in cash for $48/share incl acquired net cash of $315m ANNOUNCED 2019-10-10
N-Side–Sciad Communications: public relations, 201910 service existent by Sciad 2019-10-09
Illumina–Qiagen: sequencing-based IVD tests, 201910–2034 collab 15y strategic alliance combining sequencing technology + assays + automation + s/w 2019-10-07
Immunexpress–SEVERAL: investment, 201910 private financing round 2019-10-03
Univercells–EU (govt): credit, 201910– EIB loan €20m to advance vaccine portfolio 2019-10-03
AstraZeneca–N-Side: clinical supply chain management s/w, 201910– supply implementation of cloud-based N-Side Suite for Clincial Trials 2019-10-01
Cellectis–Lonza: cell therapy contract manufacturing, 201910– supply UCART cell therapy candidates by Lonza in Geleen (NL) 2019-10-01
Oncimmune–IPF Partners: credit, 201909– 202309 credit facility €8.5m four year incl warrant for 2m new ordinary shares IPF Management SA 2019-09-20
Menarini–BlueBee: bioinformatics, –201909 collab developm of MSBiosuite using BlueBee genomics data platoform 2019-09-19
Novigenix–BioLizard: bioinformatics, 201909– collab developm of AI-based bioinformatics algorithm to support developm of tests for LITOseek platform 2019-09-19
Versantis–SEVERAL: investment, 201909 financing round Series B CHF16m led by Swisscanto Invest by ZKB 2019-09-18
Pharvaris–Bain Capital: investment, 201909 financing round Series B totalling $66m incl new + co-investor Bain Capital Life Sciences 2019-09-10
Pharvaris–Foresite Capital: investment, 201909 financing round Series B totalling $66m incl new + lead investor Foresite Capital 2019-09-10
Pharvaris–Idinvest Partners: investment, 201909 financing round Series B totalling $66m incl existing + co-investor Idinvest Partners 2019-09-10
Pharvaris–Kurma: investment, 201909 financing round Series B totalling $66m incl existing + co-investor Kurma Partners 2019-09-10
Pharvaris–Life Sciences Partners: investment, 201909 financing round Series B totalling $66m incl existing + co-investor LSP 2019-09-10
Pharvaris–Rockefeller: investment, 201909 financing round Series B totalling $66m incl new + co-investor Venrock Partners 2019-09-10
Pharvaris–SEVERAL: investment, 201909 financing round Series B $66m led by Foresite Capital 2019-09-10
Pharvaris–VenBio: investment, 201909 financing round Series B totalling $66m incl new + co-investor venBio Partners 2019-09-10
iStar Medical–Belgium (govt): investment, 201909 financing round Series C totalling €40m incl existing + co-investor SFPI-FPIM 2019-09-05
iStar Medical–BNP Paribas: investment, 201909 financing round Series C totalling €40m incl new + co-investor BNP Paribas Fortis Private Equity 2019-09-05
iStar Medical–Capricorn Venture Partners: investment, 201909 financing round Series C totalling €40m incl existing + co-investor Capricorn 2019-09-05
iStar Medical–Earlybird: investment, 201909 financing round Series C totalling €40m incl new + co-investor Earlybird 2019-09-05
iStar Medical–Gimv: investment, 201909 financing round Series C totalling €40m incl new + co-lead investor Gimv 2019-09-05
iStar Medical–Life Sciences Partners: investment, 201909 financing round Series C totalling €40m incl new + co-lead investor LSP Health Economics 2 2019-09-05
iStar Medical–Optimum Strategic Communications: public relations, 201909 service existent by Optimum 2019-09-05
iStar Medical–SEVERAL: investment, 201905 financing round Series C €40m led by LSP + Gimv 2019-09-05
iStar Medical–Wallonia (govt): investment, 201909 financing round Series C totalling €40m incl existing + co-investor SRIW 2019-09-05
Curetis–OpGen: investment, 201909– reverse merger with Curetis shareholders holding 72.5% of combined entity 2019-09-04
Uniqure–SEVERAL: investment, 201909 public offering $225m+$34m with 4.9m+734k ordinary shares at $46/share 2019-09-04
Achilles Therapeutics–RA Capital Management: investment, 201909 financing round Series B totalling £100m incl new + lead investor RA Capital 2019-09-03
Achilles Therapeutics–SEVERAL: investment, 201909 financing round Series B £100m led by RA Capital Management 2019-09-03
Curetis–HC Wainwright: investment banking, 201908– supply service Curetis retains HC Wainwright to evaluate all strategic options 2019-08-12
Blue Heron–Eurofins: investment, 201908 acquisition of Blue Heron Biotech by Eurofins Genomics LLC 2019-08-06
Imcyse–Andrew Lloyd Associates: public relations, 201908 service existent by ALA 2019-08-05
Alizé Pharma–SEVERAL: investment, 201907 financing round Series A €67m of Alizé Pharma 3 led by LSP 2019-07-31
Ako med–Curetis: Unyvero system, 201907– distribution excl 3y Unyvero A50 system + cartridges in Serbia + Bosnia + North Macedonia + Montenegro 2019-07-30
Breath Therapeutics–Zambon: investment, 201907 acquisition €140m + €360m milestones by Zambon 2019-07-25
Medicxi Ventures–JnJ: investment, 201907 closing totalling €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
Medicxi Ventures–Novartis: investment, 201907 closing totalling €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
Medicxi Ventures–SEVERAL: investment, 201907 closing €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
AM-Pharma–SEVERAL: investment, 201907 financing round €116m co-led by LSP + Andera Partners 2019-07-16
Ncardia–Evotec: investment, 201907 acquisition €na of iPSC assets + 17 strong team of bankrupt Ncardia AG in Cologne 2019-07-15
Galapagos–Gilead: investment, 201907 equity investment $1.1b at €140.59/share raising share from 12.3% to 22% as part of collab 2019-07-14
Gilead–Galapagos: drug research + development, 201907–202906 strategic 10y collab $3.9b upfront + $1.1b equity investment + milestones 2019-07-14
Citryll–BrightGene: investment, 201907 first closing of a targeted €15m financing round Series A incl investor BrightGene International Ltd 2019-07-03
Citryll–Curie Capital: investment, 201907 first closing of a targeted €15m financing round Series A incl investor Curie Capital 2019-07-03
Citryll–ModiQuest: investment, 201907 first closing of a targeted €15m financing round Series A incl investor ModiQuest BV 2019-07-03
Citryll–Netherlands (govt): investment, 201907 first closing of a targeted €15m financing round Series A incl investor BOM Brabant Ventures 2019-07-03
Citryll–SEVERAL: investment, 201907 first closing of targeted €15m financing round Series A with ModiQuest + BOM + BrightGene + Curie Capital 2019-07-03
CryoTherapeutics–SEVERAL: investment, 201906 financing round Series B €7m incl equity + debt + non-dilutive cash advances 2019-06-27
Sanifit–Forbion: investment, 201906 financing round Series D totalling €55.2m incl existing + co-investor Forbion Capital Partners 2019-06-26
Sanifit–Gilde Investment: investment, 201906 financing round Series D totalling €55.2m incl existing + co-investor Gilde Healthcare 2019-06-26
Sanifit–la Caixa: investment, 201906 financing round Series D totalling €55.2m incl existing + lead investor Caixa Capital Risc 2019-06-26
Sanifit–SEVERAL: investment, 201906 financing round Series D €55.2m led by Caixa Capital Risc 2019-06-26
Sanifit–SEVERAL: investment, 201906c capitalisation of €17m of convertible bonds 2019-06-26
Forendo Pharma–Vesalius Biocapital: investment, 201906 existent investment of Vesalius Biocapital III fund 2019-06-25
Sword Health–Vesalius Biocapital: investment, 201906 existent investment of Vesalius Biocapital III fund 2019-06-25
Transplant Genomics–Eurofins: investment, 201906 acquisition of Transplant Genomics Inc by Eurofins 2019-06-25
Vesalius Biocapital–SEVERAL: investment, 201906 final closing of €120m Vesalius Biocapital III fund 2019-06-25
Gamida Cell–Lonza: cell therapy contract manufacturing, 201906– supply multi-year future commercial production of omidubicel by Lonza in Geleen (NL) 2019-06-19
Imcyse–SEVERAL: investment, 201906 financing round Series B €28m led by LSP 2019-06-18
Kiadis–SEVERAL: investment, 201905 private placment €27.6m with 3.68m new shares at €7.5/share 2019-05-30
Kiadis–Be The Match: cell therapy, 201905– collab logistical + technological solutions for ATIR101 developm in US + CA by Be The Match 2019-05-22
Storm Therapeutics–Merck (DE): investment, 201905 financing round Series A extension totalling £14m incl existing investor M Ventures 2019-05-20
Storm Therapeutics–SEVERAL: investment, 201905 financing round Series A extension £14m bringing total round to £30m incl new investor Seroba LS 2019-05-20
DNA Script–Life Sciences Partners: investment, 201905 financing round Series B totalling $38.5m incl new + lead investor LSP 2019-05-16
Inovio–Qiagen: molecular companion diagnostics, 201905– collab developm of CDx for VGX-3100 DNA-based immunotherapy for cervical dysplasia 2019-05-16
Icometrix–Bertarelli Group: investment, 201905 financing round totalling $18m incl new + lead investor Forestay Capital 2019-05-14
Icometrix–Capricorn Venture Partners: investment, 201905 financing round totalling $18m incl existing + co-investor Capricorn Venture Partners 2019-05-14
Icometrix–Optum Ventures: investment, 201905 financing round totalling $18m incl new + co-investor Optum Ventures 2019-05-14
Icometrix–SEVERAL: investment, 201905 financing round $18m led by Forestay Capital + incl Optum Ventures + Capricorn Venture Partners 2019-05-14
Confo Therapeutics–BioGeneration Ventures: investment, 201905 financing round Series A totalling €30m incl new + lead investor BGV 2019-05-07
Confo Therapeutics–Capricorn Venture Partners: investment, 201905 financing round Series A totalling €30m incl existing + co-investor Capricorn HTF 2019-05-07
Confo Therapeutics–Flanders (govt): investment, 201905 financing round Series A totalling €30m incl existing + co-investor PMV 2019-05-07
Confo Therapeutics–Fund+: investment, 201905 financing round Series A totalling €30m incl new + co-investor Fund+ 2019-05-07
Confo Therapeutics–Perceptive Advisors: investment, 201905 financing round Series A totalling €30m incl new + co-investor Perceptive Advisors 2019-05-07
Confo Therapeutics–Qbic: investment, 201905 financing round Series A totalling €30m incl existing + co-investor Qbic 2019-05-07
Confo Therapeutics–SEVERAL: investment, 201905 financing round Series A €30m led by BGV + co-led by Wellington Partners 2019-05-07
Confo Therapeutics–Univ Michigan: investment, 201905 financing round Series A totalling €30m incl existing + co-investor MINTS 2019-05-07
Confo Therapeutics–V-Bio Ventures: investment, 201905 financing round Series A totalling €30m incl existing + co-investor V-Bio Ventures 2019-05-07
Confo Therapeutics–VIB: investment, 201905 financing round Series A totalling €30m incl existing + co-investor VIB 2019-05-07
Confo Therapeutics–Wellington Partners: investment, 201905 financing round Series A totalling €30m incl new + co-lead investor Wellington Partners 2019-05-07
Promethera–Ci:z Investment: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor Ci:z Investment LLP (JP) 2019-05-07
Promethera–Korea Investment Partners: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor Korea Investment Partners 2019-05-07
Promethera–Medipal: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor Medipal Holdings Corp 2019-05-07
Promethera–Mirae Asset: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor Mirae Asset Capital 2019-05-07
Promethera–Mitsui: investment, 201905 financing round Series D totalling €39.7m incl existing + co-investor Mitsui & Co Global Investment Inc 2019-05-07
Promethera–SEVERAL: investment, 201905 financing round Series D totalling €39.7m incl Belgian private investors as co-investors 2019-05-07
Promethera–SEVERAL: investment, 201905 financing round Series D €39.7m co-led by Itochu Corp + Shinsei Capital Partners 2019-05-07
Promethera–Shinsei Capital: investment, 201905 financing round Series D totalling €39.7m incl new + co-lead investor Shinsei Capital Partners 2019-05-07
Promethera–Six Snow: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor family office Six Snow 2019-05-07
Enzyre–EU (govt): grant, 201904 EFRO grant €2m 2019-04-30
Enzyre–Optimum Strategic Communications: public relations, 201904 service existent by Optimum 2019-04-30
Enzyre–SEVERAL: investment, 201904 closing of seed financing round 2019-04-30
SGS–Veeva Systems: clinical research software, 201904– supply global implementation of Veeva Vault CTMS by SGS 2019-04-30
JnJ–Iktos: drug discovery services, 201904– collab using AI technology for small molecule drug discovery projects Janssen 2019-04-29
LabCorp–Biocartis: molecular diagnostics, 201904– collab ww €na offering of Idylla platform + oncology assays by Covance for drug development 2019-04-23
CytoSen Therapeutics–Kiadis: investment, 201904– acquisition merger in shares with 1.94m shares (7.4%) upfront plus 5.82 shares milestones 2019-04-17
Bruker Corp–Univ Nijmegen: mass spectrometry, 201904– collab establishment of joint Center of Excellence for Translational Omics at RUMC TML 2019-04-16
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page



Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px

» top